PHOENIX, AZ – February 20, 2025 – Phoenix Bioscience Core (PBC) is pleased to announce that HonorHealth Innovations (H2I) is joining Investor Corner PBC, further strengthening the region’s ecosystem for healthcare innovation and investment. Investor Corner PBC is purposely situated within Connect Labs by Wexford, a flexible, scale-in-place lab and innovation hub located at Wexford Science & Technology’s 850 PBC facility and a cornerstone of Greater Phoenix’s thriving startup ecosystem.Continue reading
Yearly Archives: 2025
A Bill at the Arizona Legislature Would Give Arizona Another Tool to Drive Growth in our Life Science Sector
Senate Bill 1539 expands the clean room transaction privilege tax (TPT) deduction and use tax exemption to include any clean room used for manufacturing, processing, fabrication or research and development, rather than only clean rooms used for manufacturing, processing, fabrication or research and development of semiconductor products. The bill received a “do pass” recommendation in the Senate Finance Committee on February 17, 2025.Continue reading
HonorHealth Research Institute taps leading anti-cancer drug development expert to head its new Center for Translational Science
Dr. Sunil Sharma’s medical prowess unifies basic scientific discoveries, translational drug development and clinical care to produce advanced treatments for patientsContinue reading
C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi
TUCSON, Ariz., February 18, 2024 — Critical Path Institute’s® (C-Path)Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi, as its newest members. Continue reading
NuvOx Announces MHRA Approval to Commence Phase IIb Stroke Trial
Tucson, AZ, February 14, 2025 –(PR.com)– NuvOx Therapeutics, Inc. (“NuvOx”) announced that The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom in collaboration with the Research Ethics Committee has accepted the amended request for a clinical trial authorisation (CTA). This acceptance will enable the company to commence the Phase IIb NOVEL trial (NanO2 in Large VessEL Occlusion Stroke (NOVEL): a multicentre single-blind, randomised, placebo-controlled blinded biomarker end-point clinical trial of perfluorocarbon in acute ischaemic stroke due to large vessel occlusion (LVO).Continue reading
Three U of A Health Sciences researchers earn Career Development Awards
The University of Arizona Health Sciences Career Development Award program is providing funding for three junior faculty members with independent research projects.Continue reading
The Stephenson Global Pancreatic Cancer Research Institute Launches First-of-Its-Kind Global Scientific Awards to Advance Breakthrough Discovery in Pancreatic Cancer
- Stephenson Global Prize opportunity invites top scientific minds for one of the largest privately funded rewards — Call for Nominations open now through March 14.
- Stephenson Global Scholar Grants seek the most innovative solutions to tackle the challenges of pancreatic cancer — Grant Applications open now through March 14.
Dr. Corey Casper Joins Banner Health as CEO of Banner Research
Dr. Corey Casper is Chief Executive Officer of Banner Research, which transforms discoveries into new diagnostic, treatment and prevention methods for diseases such as Alzheimer’s, Parkinson’s, cardiovascular disease and cancer.Continue reading
NAU achieves R1 research designation
The Carnegie Foundation announced today that Northern Arizona University received R1 research activity designation, the highest classification for research institutes in the United States.Continue reading
Arizona High School Students Invited to Explore Healthcare Careers
The Midwestern University Health Careers Institute offers a free educational opportunity for high school students. The programs is held in Glendale, AZ. Applications close April 1, 2025.Continue reading